Needle Free Injection Systems Market Size Forecast to Reach $24.25 Billion by 2025


Posted October 9, 2020 by Blessy_Joy

The High Costs of Training and Startups is Estimated to Reduce the Growth of Needle Free Injection Systems Market.

 
Needle Free Injection Systems Market size is forecast to reach $24.25 billion by 2025, growing at a CAGR of 14.3% during the forecast period 2020-2025.Needle Free Injections, also called needle-less injections, are simply an injection without the need to use needles. A needle free injection occurs when the injectable machine is pushed into the body through the skin by a combination of pressure and velocity from a syringe without a needle that has specially designed for this purpose. Increase in the prevalence of chronic diseases, needle phobia, increase in the communicable diseases owing to needle injuries is set to further enhance the overall market demand of Needle Free Injection Systems Market during the forecast period 2020-2025.

Key Takeaways

North America dominated the Needle Free Injection Systems Market in 2019 owing to rise in the expenditure of healthcare, inclination towards advanced technologies and Increase in the number of chronic and cardiac diseases.

The increase in the technology and knowledge among consumers is likely to aid in the market growth of Needle Free Injection Systems Market.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Needle Free Injection Systems Market report.

Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=16782

Geography Segment Analysis

The North America held the largest share in the Needle Free Injection Systems Market with a market share of 33.7% in 2019 of the overall market shares. This growth is owing to the factors such as Increase in the Healthcare expenditure, Inclination towards advanced technologies, increase in the number of chronic diseases such as Diabetes, Asthma and Cancer. Asia-Pacific is estimated to be the fastest growing segment during the forecast period 2020-2025 owing to the factors such as reducing the fear of needles and increase in the large number of chronic diseases, especially Diabetes

Drivers- Needle Free Injection Systems Market

Increasing incidence of communicable disease due to needle stick injuries

Even though the acute physiological effects of a needlestick injury are generally negligible, these injuries can lead to transmission of blood-borne diseases, placing those exposed at increased risk of infection from disease causing pathogens, such as the hepatitis B virus (HBV), hepatitis C virus (HCV). This in thus is driving demand for Needle Free Injection System Market.

Needle Free Injection Systems-Industry Outlook

Needle Free Injection Systems top 10 companies are Medical International Technology (MIT), Injex Pharma AG, Endo International PLC, Antares Pharma, Biojet Medical Technologies Inc, National Medical Products Co Ltd, Glide Pharmaceutical Technologies Limited, Valeritas Inc, Inovia Pharmaceuticals, European Pharma Group among others.

About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Blessy
Business Address IndustryARC
Country India
Categories Business
Tags needle free injection systems market , needle free injection systems market research , needle free injection systems market share , needle free injection systems market size
Last Updated October 9, 2020